LIVER CANCER NEWS TIPS & FEATURES


OMNI Health Media is a leading online provider of Daily Health News. OMNI’s Cabometyx News provides summaries of developments in the prevention, screening, and management of Gastrointestinal Health Conditions as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating new therapies and supportive care strategies in order to better educate patients and their caregivers, ensuring timely access to the best care available.
Cabometyx™ May Be 'New Treatment Option' for Liver Cancer

February 20, 2018

Cabometyx™ May Be ‘New Treatment Option’ for Liver Cancer

By Anonymous User anonymous_user_10987

CancerConnect News:  Treatment with Cabometyx  (cabozantinib) significantly improved outcomes in patients with advanced hepatocellular carcinoma (HCC), leading researchers to suggest that it could offer a new treatment option for this patient population.  The new findings come from the phase 3 CELESTIAL trial and were presented at the 2018 Gastrointestinal Cancers Symposium.1 About Liver Cancer Liver […]

View full entry

Tags: Cabometyx, cabozantinib, hepatocellular cancer, Liver Cancer, News Tips and Features, News Tips and Features Other


View more articles like this
More news and in-depth Liver Cancer information

CONDITIONS OF THE GI TRACT